Connect Sign In
THC (Cannabinoids), Urine Screen with Reflex to Quantitation
Ordering Recommendation
Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out cannabinoid exposure. For follow-up testing of a presumptive result, THC Metabolite, Urine, Quantitative (0090369) is preferred.
This test does not distinguish between the delta-8 and delta-9 forms of THC or their metabolites.
New York DOH Approval Status
Specimen Required
Random urine.
Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2 mL)
Room temperature.
Breast milk.
Ambient: 1week; Refrigerated: 1 month; Frozen: 1 month
Methodology
Qualitative Enzyme Multiplied Immunoassay Technique (EMIT)/Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-4 days
Reference Interval
Interpretive Data
Methodology: Immunoassay
Positive Cutoff: 50 ng/mL
FDA
Note
If the specimen screens positive, then Confirmation/Quantitation by LC-MS/MS (ARUP test code 0090369) will be added to confirm result. Additional charges apply.
Compare to Pain Management, Marijuana Metabolite, Quantitative, with medMATCH, Urine; Pain Management, Marijuana Metabolite, with Confirmation with medMATCH, Urine.
Hotline History
CPT Codes
80307; if reflexed, add 80349 (Reflexed Alt Code: G0480 )
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0092195 | THC (Cannabinoids) Screen, Urine | 19292-2 |
| 2012212 | Screen, Urine Interpretation | 54247-2 |
Aliases
- Marijuana
- Marinol
- 9-carboxy-THC
- Cannabinoids
- Cannabis
- Dronabinol
- Pain Management
- THC
